Cardiovascular effects of electronic cigarettes
- PMID: 28332500
- PMCID: PMC5519136
- DOI: 10.1038/nrcardio.2017.36
Cardiovascular effects of electronic cigarettes
Abstract
Cardiovascular safety is an important consideration in the debate on the benefits versus the risks of electronic cigarette (EC) use. EC emissions that might have adverse effects on cardiovascular health include nicotine, oxidants, aldehydes, particulates, and flavourants. To date, most of the cardiovascular effects of ECs demonstrated in humans are consistent with the known effects of nicotine. Pharmacological and toxicological studies support the biological plausibility that nicotine contributes to acute cardiovascular events and accelerated atherogenesis. However, epidemiological studies assessing Swedish smokeless tobacco, which exposes users to nicotine without combustion products, generally have not found an increased risk of myocardial infarction or stroke among users, but suggest that nicotine might contribute to acute cardiovascular events, especially in those with underlying coronary heart disease. The effects of aldehydes, particulates, and flavourants derived from ECs on cardiovascular health have not been determined. Although ECs might pose some cardiovascular risk to users, particularly those with existing cardiovascular disease, the risk is thought to be less than that of cigarette smoking based on qualitative and quantitative comparisons of EC aerosol versus cigarette smoke constituents. The adoption of ECs rather than cigarette smoking might, therefore, result in an overall benefit for public health.
Conflict of interest statement
N.L.B. has been a consultant to GlaxoSmithKline and Pfizer, pharmaceutical companies that market medications to aid smoking cessation, and has served as a paid expert witness in litigation against tobacco companies. J.B.F. declares no competing interests.
Figures
References
-
- Farsalinos KE, Poulas K, Voudris V, Le Houezec J. Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction. 2016;111:2032–2040. - PubMed
-
- Syamlal G, Jamal A, King B, Mazurek J. Electronic cigarette use among working adults — United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65:557–561. - PubMed
-
- Britton J, Arnott D, McNeill A, Hopkinson N. Nicotine without smoke-putting electronic cigarettes in context. BMJ. 2016;353:i1745. - PubMed
-
- U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. NCBI. 2010 http://www.ncbi.nlm.nih.gov/books/NBK53017/pdf/BookshelfNBK53017.pdf. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
